Key points are not available for this paper at this time.
May support β-blockade in chronic HF but should not change practice; leaves open confirmation in contemporary trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Michael R. Bristow (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: